Literature DB >> 26092054

Crescentic glomerulonephritis and membranous nephropathy: a rare coexistence.

Olga Balafa1, Rigas Kalaitzidis, Georgios Liapis, Sofia Xiromeriti, Fotios Zarzoulas, Georgios Baltatzis, Moses Elisaf.   

Abstract

BACKGROUND: The coexistence of crescents and membranous glomerulonephritis (MGN) is a special characteristic in lupus nephritis. In the absence of the characteristic histological features of lupus nephritis, MGN with crescents should raise the possibility of two other histopathological entities: anti-GBM disease and necrotizing and crescentic glomerulonephritis. The last one includes patients with positive ANCA serology or not. RESULTS AND
CONCLUSIONS: Here, we describe a case of a male patient who presented with extrarenal vasculitis symptoms, acute renal failure, hematuria and nephrotic-range proteinuria. ANCA serology was positive, and the biopsy revealed crescentic vasculitis plus membranous nephropathy. Reviewing the whole literature about similar histological cases, we included 38 cases with ANCA-positive serology and 30 ones with no ANCA in serum. It seems that in the first category vasculitis symptoms predominate, while in the second one these symptoms are absent. Their histological features have no major differences. In any case, the clinical course of these patients is serious, and in most cases, immunosuppression is essential in order to avoid end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26092054     DOI: 10.1007/s11255-015-1031-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  29 in total

1.  Crescentic transformation of membranous glomerulopathy: a reversible condition.

Authors:  Andrew M Hall; Emily M Symington; Stephen A Sampson; Jonathan T C Kwan
Journal:  Nephrol Dial Transplant       Date:  2005-12-06       Impact factor: 5.992

Review 2.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

3.  Acute renal failure in membranous glomerulonephropathy: a result of superimposed crescentic glomerulonephritis.

Authors:  S H James; Y H Lien; S J Ruffenach; G E Wilcox
Journal:  J Am Soc Nephrol       Date:  1995-12       Impact factor: 10.121

Review 4.  Membranous nephropathy: recent travels and new roads ahead.

Authors:  Laurence H Beck; David J Salant
Journal:  Kidney Int       Date:  2010-02-24       Impact factor: 10.612

5.  [Case of MPO-ANCA-associated vasculitis with membranous nephropathy].

Authors:  Sayaka Watanabe; Yoshihiro Arimura; Kazufumi Nomura; Soko Kawashima; Ken Yoshihara; Shinya Kaname; Akira Yamada
Journal:  Nihon Jinzo Gakkai Shi       Date:  2011

6.  Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases.

Authors:  Mark Haas; Joseph A Eustace
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

7.  Membranous nephropathy with crescents: a series of 19 cases.

Authors:  Erika F Rodriguez; Samih H Nasr; Christopher P Larsen; Sanjeev Sethi; Mary E Fidler; Lynn D Cornell
Journal:  Am J Kidney Dis       Date:  2014-04-04       Impact factor: 8.860

8.  A case of membranous nephropathy and myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Authors:  Zhi-Juan Hu; Kai Niu; Bing Liu; Ya-Nan Shi
Journal:  Exp Ther Med       Date:  2014-07-17       Impact factor: 2.447

9.  A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy.

Authors:  Michiko Shimada; Takeshi Fujita; Norio Nakamura; Ikuyo Narita; Yuko Shimaya; Reiichi Murakami; Hideaki Yamabe; Hiroshi Osawa; Ken Okumura
Journal:  BMC Nephrol       Date:  2013-03-28       Impact factor: 2.388

10.  Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy.

Authors:  Sheena Surindran; Rivka Ayalon; Nazia Hasan; Laurence H Beck; David J Salant; Laura Barisoni; Edward Y Skolnik; Lada Beara-Lasic
Journal:  Clin Kidney J       Date:  2012-03-09
View more
  7 in total

1.  Immunosuppression in idiopathic membranous nephropathy: A double-edge sword.

Authors:  Vincenzo L'Imperio; Elena Ajello; Maurizio Garozzo; Antonella Tosoni; Franco Ferrario; Fabio Pagni
Journal:  Int J Immunopathol Pharmacol       Date:  2016-07-06       Impact factor: 3.219

2.  Crescentic Glomerulonephritis and Membranous Nephropathy: A Rare Overlap.

Authors:  Mohamedanwar Ghandour; Heba Osman; Samer Alkassis; Alix Charles; Kristina Zalewski; Jarrett Weinberger; Yahya Malik-Osman; Zeenat Y Bhat
Journal:  Case Rep Nephrol       Date:  2022-06-24

3.  Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report.

Authors:  Crislaine Aparecida da Silva; Fabiano Bichuette Custódio; Maria Luíza Gonçalves Dos Reis Monteiro; Stanley de Almeida Araújo; Liliane Silvano Araújo; Rosana Rosa Miranda Côrrea; Marlene Antônia Dos Reis; Juliana Reis Machado
Journal:  J Bras Nefrol       Date:  2019-02-25

4.  Plasma exchange and rituximab treatments in primary membranous nephropathy combined with crescentic glomerulonephritis: A case report.

Authors:  Hui Lu; Zhao Cui; Xu-Jie Zhou; Qi-Zhuang Jin; Xiao-Juan Yu; Su-Xia Wang; Yu Wang; Fu-de Zhou; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.

Authors:  Shuai Wang; Jin Shang; Jing Xiao; Zhanzheng Zhao
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

6.  Membranous Nephropathy with Rapid Progression.

Authors:  R Vairakkani; K Thirumal Valavan; M Edwin Fernando; T Yashwanth Raj
Journal:  Indian J Nephrol       Date:  2019-12-27

7.  Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab.

Authors:  Shun Yoshida; Shunichiro Hanai; Daiki Nakagomi; Kei Kobayashi; Kazuya Takahashi; Fumihiko Furuya
Journal:  Intern Med       Date:  2020-08-22       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.